Literature DB >> 17191313

Surgical experiences of functioning neuroendocrine neoplasm of the pancreas.

Chang Moo Kang1, Se Ho Park, Kyung Sik Kim, Jin Sub Choi, Woo Jung Lee, Byong Ro Kim.   

Abstract

We present our surgical experiences with functioning neuroendocrine neoplasms of the pancreas to define its natural history, and to suggest its proper management. From June 1990 to June 2005, patients with diagnosis of functioning neuroendocrine (islet cell) neoplasms of the pancreas were retrospectively reviewed. Fourteen patients (5 men and 9 women) with a median age of 49 years (range, 12 - 68 years) were identified. Twelve patients (86%) had insulinoma, two (14%) had gastrinoma. One (7%) with pancreatic insulinoma was multiple endocrine neoplasia type 1. Intraoperative ultrasound scan (sensitivity, 83%) was the most powerful modality for tumor localization. Fifteen neoplasms with median tumor size 1 cm (range 0-3 cm) were resected. Four insulinomas (26.7%) were located in the head of the pancreas and 5 (36%), in the tail. Another 5 (36%) insulinomas and 1 (7%) gastrinoma were located around the neck area near the SMV or PV. Eleven patients (79%) underwent enucleation, and 2 patients (14%), distal pancreatectomy with splenectomy. 100% of patients with functioning neuroendocrine neoplasms of the pancreas have survived. The overall disease free 10-year survival was found to be about 81%. Exact localization of tumor by intraoperative ultrasound and surgical removal are promising for good prognosis.

Entities:  

Mesh:

Year:  2006        PMID: 17191313      PMCID: PMC2687824          DOI: 10.3349/ymj.2006.47.6.833

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  14 in total

1.  Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome.

Authors:  F Yu; D J Venzon; J Serrano; S U Goebel; J L Doppman; F Gibril; R T Jensen
Journal:  J Clin Oncol       Date:  1999-02       Impact factor: 44.544

2.  Robotic resection of pancreatic neuroendocrine tumor.

Authors:  W S Melvin; B J Needleman; K R Krause; E C Ellison
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2003-02       Impact factor: 1.878

3.  Islet cell hyperplasia of the pancreas presenting as hyperinsulinemic hypoglycemia in an adult.

Authors:  Y W Kim; Y K Park; J H Park; S M Lee; J Lee; S W Ko; M H Yang
Journal:  Yonsei Med J       Date:  2000-06       Impact factor: 2.759

Review 4.  The surgical management of pancreatic neuroendocrine tumors.

Authors:  K Azimuddin; R S Chamberlain
Journal:  Surg Clin North Am       Date:  2001-06       Impact factor: 2.741

Review 5.  Anatomic distribution of pancreatic endocrine tumors.

Authors:  T J Howard; B E Stabile; M J Zinner; S Chang; B S Bhagavan; E Passaro
Journal:  Am J Surg       Date:  1990-02       Impact factor: 2.565

6.  Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas.

Authors:  M A Anderson; S Carpenter; N W Thompson; T T Nostrant; G H Elta; J M Scheiman
Journal:  Am J Gastroenterol       Date:  2000-09       Impact factor: 10.864

7.  Surgical experience with functioning pancreatic neuroendocrine tumors.

Authors:  Brent D Matthews; Trina I Smith; Kent W Kercher; Walter D Holder; B Todd Heniford
Journal:  Am Surg       Date:  2002-08       Impact factor: 0.688

8.  Pancreatic endocrine tumors.

Authors:  P U Heitz; M Kasper; J M Polak; G Klöppel
Journal:  Hum Pathol       Date:  1982-03       Impact factor: 3.466

9.  [Laparoscopic pancreatectomy: a series of 22 patients].

Authors:  M Gagner; W B Inabnet; L Biertho; B Salky
Journal:  Ann Chir       Date:  2004-02

10.  Insulinoma. The value of intraoperative ultrasonography.

Authors:  C S Grant; J van Heerden; J W Charboneau; E M James; C C Reading
Journal:  Arch Surg       Date:  1988-07
View more
  5 in total

Review 1.  Non-functional pancreatic neuroendocrine tumor as an incidentaloma--a case report and review of literature.

Authors:  Tarun Rustagi; Mridula Rai; Frank Bauer
Journal:  J Gastrointest Cancer       Date:  2013-09

2.  Necrosis and angioinvasion predict adverse outcome in pancreatic neuroendocrine tumors after curative surgical resection: results of a single-center series.

Authors:  Resit Demir; Johann Pohl; Abbas Agaimy; Georgios Peros; Aristoteles Perrakis; Susanne Merkel; Werner Hohenberger; Peter Klein
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

Review 3.  Non-functioning pancreatic neuroendocrine tumors--a case report and review of literature.

Authors:  Murtuza M Rampurwala; Anupam Kumar; Subramanian Kannan; Pamela Kowalczyk; Surendra Khera
Journal:  J Gastrointest Cancer       Date:  2011-12

Review 4.  Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.

Authors:  Thorvardur R Halfdanarson; Joseph Rubin; Michael B Farnell; Clive S Grant; Gloria M Petersen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

5.  Minimally invasive vs open pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors.

Authors:  Juwan Kim; Ho Kyoung Hwang; Woo Jung Lee; Chang Moo Kang
Journal:  World J Gastrointest Oncol       Date:  2020-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.